These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2906334)

  • 21. Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study.
    Tran A; Villeneuve JP; Bilodeau M; Willems B; Marleau D; Fenyves D; Parent R; Pomier-Layrargues G
    Am J Gastroenterol; 1999 Oct; 94(10):2909-11. PubMed ID: 10520843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of estrogen replacement therapy on lipids. Implications for cardiovascular risk.
    LaRosa JC
    J Reprod Med; 1985 Oct; 30(10 Suppl):811-3. PubMed ID: 4078813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is estrogen replacement therapy necessary?
    Hammond CB; Nachtigall LE
    J Reprod Med; 1985 Oct; 30(10 Suppl):797-801. PubMed ID: 4078811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bleeding disorders. Hazards of hormone treatment].
    Vesterdal A
    Sygeplejersken; 1993 Jun; 93(26):16. PubMed ID: 8140519
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cetyltrimethylammonium naproxenate as vaginal lavage in the therapy of vulvovaginal dystrophies in the postmenopause].
    Plotti G; Gozzi G; Bobbio C; Giulianelli G; Buttini G
    Minerva Ginecol; 1994 Oct; 46(10):583-6. PubMed ID: 7838418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Topical hormonal treatment and urogenital atrophy].
    Sitruk-Ware R; Thomas JL
    Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of disorders of the climacteric by vaginal, rectal and transdermal estrogen substitution].
    Lauritzen C
    Gynakologe; 1986 Dec; 19(4):248-53. PubMed ID: 3817597
    [No Abstract]   [Full Text] [Related]  

  • 28. Increased incidence of symptomatic cholesterol cholelithiasis in perimenopausal women receiving estrogen replacement therapy: a retrospective study.
    Honoré LH
    J Reprod Med; 1980 Oct; 25(4):187-90. PubMed ID: 6253639
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of intracervical estrogen administration in uterine hypoplasia].
    Cekański A; Peteja J
    Wiad Lek; 1980 May; 33(10):787-90. PubMed ID: 6893245
    [No Abstract]   [Full Text] [Related]  

  • 30. Symposium: Update and advances in intravenous therapy with trimethoprim-sulfamethoxazole. San Francisco, California, July 15, 1985. Proceedings.
    Rev Infect Dis; 1987; 9 Suppl 2():S153-229. PubMed ID: 3495026
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of combined synthetic progestins on blood coagulation properties and alpha 2-glycoprotein content].
    Lutsik LA
    Sov Med; 1981; (2):52-5. PubMed ID: 7244809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen use and cardiovascular disease.
    Henderson BE; Ross RK; Paganini-Hill A
    J Reprod Med; 1985 Oct; 30(10 Suppl):814-20. PubMed ID: 4078814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Augmentation of prolactin secretion by estrogen in hypogonadal women.
    Yen SS; Ehara Y; Siler TM
    J Clin Invest; 1974 Feb; 53(2):652-5. PubMed ID: 11344580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Estrogen therapy and vascular risk].
    Basdevant A; Mauvais-Jarvis P
    Nouv Presse Med; 1980 Jun; 9(25):1753-6. PubMed ID: 7383869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proceedings of the Clinical SPECT Symposium. February 23-24, 1987, San Francisco, California.
    Am J Physiol Imaging; 1987; 2(3):127-66. PubMed ID: 3502530
    [No Abstract]   [Full Text] [Related]  

  • 36. Time, dose and fractionation in the radiation therapy of cancer. 22nd annual San Francisco Cancer Symposium. San Francisco, Calif., March 7 and 8, 1987. Proceedings.
    Front Radiat Ther Oncol; 1988; 22():1-193. PubMed ID: 3350349
    [No Abstract]   [Full Text] [Related]  

  • 37. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.
    Ettinger B; Pressman A
    Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of postmenopausal osteoporosis by estrogen/gestagen substitution therapy.
    Riis B; Christiansen C
    Med Klin (Munich); 1987 Mar; 82(6):238-41. PubMed ID: 3587168
    [No Abstract]   [Full Text] [Related]  

  • 39. [Osteoporosis--pathogenesis, prevention, therapy].
    Dambacher MA; Ittner J; Rüegsegger P
    Internist (Berl); 1986 Mar; 27(3):206-13. PubMed ID: 3519506
    [No Abstract]   [Full Text] [Related]  

  • 40. [Low-dose estrogens in the treatment of the climacteric syndrome].
    Kolarov G; Nalbanski B; Kamenov Z; Protich M; Obretsova M; Sirakov M
    Akush Ginekol (Sofiia); 1998; 37(4):1-4. PubMed ID: 10360038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.